These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. A need to redefine the consensus on the use of statins in coronary heart disease prevention. Fruchart JC Eur Heart J; 2000 Oct; 21(19):1572-3. PubMed ID: 10988008 [No Abstract] [Full Text] [Related]
14. Pravastatin therapy and the risk of stroke. Brett AS N Engl J Med; 2000 Dec; 343(25):1894-5; author reply 1895-6. PubMed ID: 11117988 [No Abstract] [Full Text] [Related]
15. Economic benefit analysis of primary prevention with pravastatin. Modelling economic benefits after such long term treatment is inappropriate. Pharoah P BMJ; 1998 Apr; 316(7139):1241-2. PubMed ID: 9553009 [No Abstract] [Full Text] [Related]
16. The clofibrate saga: a retrospective commentary. Oliver M Br J Clin Pharmacol; 2012 Dec; 74(6):907-10. PubMed ID: 22486628 [No Abstract] [Full Text] [Related]
17. Reduction of coronary events by pravastatin--is lowering low-density lipoprotein cholesterol the answer? Halle M; Bery A; Keul J Am J Cardiol; 1997 Sep; 80(5):683. PubMed ID: 9295011 [No Abstract] [Full Text] [Related]
18. Statins in acute coronary syndromes: from bench to bedside. Jackson G Int J Clin Pract; 2001 Sep; 55(7):427-8. PubMed ID: 11594247 [No Abstract] [Full Text] [Related]
19. The effect of pravastatin on coronary events after myocardial infarction. Hazzard WR; Ettinger WH N Engl J Med; 1997 Mar; 336(13):961; author reply 962. PubMed ID: 9072700 [No Abstract] [Full Text] [Related]
20. Statin therapy for prevention of coronary artery disease with average cholesterol levels. Gambhir DS Indian Heart J; 1999; 51(1):19-20, 105. PubMed ID: 10327772 [No Abstract] [Full Text] [Related] [Next] [New Search]